229 related articles for article (PubMed ID: 24793000)
1. Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysis.
Petrelli F; De Stefani A; Raspagliesi F; Lorusso D; Barni S
Gynecol Oncol; 2014 Jul; 134(1):166-71. PubMed ID: 24793000
[TBL] [Abstract][Full Text] [Related]
2. Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.
Ma S; Wang J; Han Y; Guo F; Chen C; Chen X; Zou W
Gynecol Oncol; 2019 Jul; 154(1):246-252. PubMed ID: 31005286
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
Umayahara K; Takekuma M; Hirashima Y; Noda SE; Ohno T; Miyagi E; Hirahara F; Hirata E; Kondo E; Tabata T; Nagai Y; Aoki Y; Wakatsuki M; Takeuchi M; Toita T; Takeshima N; Takizawa K
Gynecol Oncol; 2016 Feb; 140(2):253-8. PubMed ID: 26701414
[TBL] [Abstract][Full Text] [Related]
4. Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a single institution.
Kinjyo Y; Nagai Y; Toita T; Kudaka W; Ariga T; Shimoji Y; Nakasone T; Taira Y; Arakaki Y; Nakamoto T; Wakayama A; Ooyama T; Maemoto H; Heianna J; Aoki Y
Br J Radiol; 2017 Aug; 90(1076):20170241. PubMed ID: 28707541
[TBL] [Abstract][Full Text] [Related]
5. Concurrent weekly single cisplatin vs triweekly cisplatin alone with radiotherapy for treatment of locally advanced cervical cancer: a meta-analysis.
Zhu J; Ji S; Hu Q; Chen Q; Liu Z; Wu J; Gu K
Cancer Manag Res; 2018; 10():1975-1985. PubMed ID: 30034252
[TBL] [Abstract][Full Text] [Related]
6. Weekly Versus Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Cervical Cancer: A Meta-Analysis.
Chen X; Zou H; Li H; Lin R; Su M; Zhang W; Zhou Y; Zhang P; Hou M; Deng X; Zou C
Int J Gynecol Cancer; 2017 Feb; 27(2):344-349. PubMed ID: 27984377
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety Evaluation of the Various Therapeutic Options in Locally Advanced Cervix Cancer: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.
Datta NR; Stutz E; Gomez S; Bodis S
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):411-437. PubMed ID: 30391522
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase 3 trial comparing 2 cisplatin dose schedules in 326 patients with locally advanced squamous cell cervical carcinoma: long-term follow-up.
Nagy VM; Ordeanu C; Coza O; Alin CR; Traila A; Todor N
Int J Gynecol Cancer; 2012 Nov; 22(9):1538-44. PubMed ID: 23070071
[TBL] [Abstract][Full Text] [Related]
9. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis.
Datta NR; Stutz E; Liu M; Rogers S; Klingbiel D; Siebenhüner A; Singh S; Bodis S
Gynecol Oncol; 2017 May; 145(2):374-385. PubMed ID: 28188016
[TBL] [Abstract][Full Text] [Related]
10. Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer.
Einstein MH; Novetsky AP; Garg M; Hailpern SM; Huang GS; Glueck A; Fields AL; Kalnicki S; Goldberg GL
Cancer; 2007 Jan; 109(1):48-53. PubMed ID: 17123270
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
12. Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: a systematic review and meta-analysis of published studies.
Petrelli F; Coinu A; Riboldi V; Borgonovo K; Ghilardi M; Cabiddu M; Lonati V; Sarti E; Barni S
Oral Oncol; 2014 Nov; 50(11):1041-8. PubMed ID: 25176576
[TBL] [Abstract][Full Text] [Related]
13. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis.
Lukka H; Hirte H; Fyles A; Thomas G; Elit L; Johnston M; Fung MF; Browman G;
Clin Oncol (R Coll Radiol); 2002 Jun; 14(3):203-12. PubMed ID: 12109823
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Analysis of Concurrent Chemoradiation with Triweekly Cisplatin plus 5-Fluorouracil Versus Weekly Cisplatin in Cervical Cancer.
Sonoda K; Yahata H; Ichinoe A; Okugawa K; Kaneki E; Kawano Y; Kenjo H; Ohgami T; Yagi H; Ohga S; Asai K; Nakamura K; Honda H; Kato K
Anticancer Res; 2015 Jun; 35(6):3447-54. PubMed ID: 26026109
[TBL] [Abstract][Full Text] [Related]
15. Weekly versus triweekly cisplatin-based concurrent chemoradiotherapy in the treatment of locally advanced cervical carcinoma: An updated meta-analysis based on randomized controlled trials.
Zhu J; Zhang Z; Bian D; Chen Q; Hu Q; Ji S; Gu K
Medicine (Baltimore); 2020 Jan; 99(1):e18663. PubMed ID: 31895831
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of concurrent weekly carboplatin with radiotherapy in the treatment of cervical cancer: A meta-analysis.
Xue R; Cai X; Xu H; Wu S; Huang H
Gynecol Oncol; 2018 Sep; 150(3):412-419. PubMed ID: 29996970
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
[TBL] [Abstract][Full Text] [Related]
19. Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis.
Tzioras S; Pavlidis N; Paraskevaidis E; Ioannidis JP
Cancer Treat Rev; 2007 Feb; 33(1):24-38. PubMed ID: 17112673
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes of neoadjuvant chemotherapy-related strategies compared with concurrent chemoradiotherapy for locally advanced cervical cancer: a meta-analysis of randomized controlled trials.
Wang B; Tan Y; Yang X; Man X
Arch Gynecol Obstet; 2021 Aug; 304(2):485-493. PubMed ID: 33389099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]